Enhancing blood sugar control boosts brain health for people with type 2 diabetes

October 02, 2020

Controlling blood sugar levels improved the ability to clearly think, learn and remember among people with type 2 diabetes who were overweight, a new study shows. But losing weight, especially for people who were obese, and increasing physical activity produced mixed results.

"It's important to properly control your blood sugar to avoid the bad brain effects of your diabetes," said
The new paper examined close to 1,100 participants in the Look AHEAD (Action for Health In Diabetes) study. One group of participants was invited to three sessions each year that focused on diet, physical activity, and social support. The other group changed their diet and physical activity through a program designed to help them lose more than 7 percent of their body weight in a year and maintain that weight loss. Cognitive tests - tests of thinking, learning, and remembering - were given to participants between 8 to 13 years after they started the study.

The research team theorized that people with greater improvements in blood sugar levels, physical activity and weight loss would have better cognitive test scores. This hypothesis proved partially true. Reducing your blood sugar levels did improve test scores. But losing more weight and exercising more did not always raise cognitive test scores.

"Every little improvement in blood sugar control was associated with a little better cognition," Dr. Carmichael said. "Lowering your blood sugar from the diabetes range to prediabetes helped as much as dropping from prediabetes levels to the healthy range."

More weight loss was either better or worse depending on the mental skill involved, Dr. Carmichael said. People who lost more weight improved their executive function skills: short-term memory, planning, impulse control, attention, and the ability to switch between tasks. But their verbal learning and overall memory declined.

"The results were worse for people who had obesity at the beginning of the study. That's a 'too little, too late' type of message," he said. "People with diabetes who let their obesity go too far, for too long may be past the point of no return, cognition-wise."

Increasing physical activity also generated more benefits for people who had overweight compared to those with obesity, the study shows.

Finding a way to offset the health effects of type 2 diabetes is vital. More than 25 percent of U.S. adults 65 or older have type 2 diabetes. The disease doubles the risk of cognitive impairment and dementia, including Alzheimer's disease, and greatly increases health care needs and costs.
-end-
The article was published in The Journal of Clinical Endocrinology and Metabolism.

About the Pennington Biomedical Research Center

The Pennington Biomedical Research Center is at the forefront of medical discovery as it relates to understanding the triggers of obesity, diabetes, cardiovascular disease, cancer and dementia. The Center conducts basic, clinical, and population research, and is affiliated with Louisiana State University. The research enterprise at Pennington Biomedical includes over 450 employees within a network of 40 clinics and research laboratories, and 13 highly specialized core service facilities. Its scientists and physician/scientists are supported by research trainees, lab technicians, nurses, dietitians, and other support personnel. Pennington Biomedical is located in state-of-the-art research facilities on a 222-acre campus in Baton Rouge, Louisiana. For more information, see
http://www.pbrc.edu.

Pennington Biomedical Research Center
6400 Perkins Road
Baton Rouge, LA 70808

Pennington Biomedical Research Center

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.